Kitima Boonvisudhi

Kitima Boonvisudhi practices at McKenzie-Willamette Medical Center in Springfield, Oregon, part of Health Side Partners.

Kitima Boonvisudhi's NPI, 1134198005, was assigned on March 14, 2006. Kitima Boonvisudhi graduated from University of Pittsburgh School of Medicine in 1994. Kitima Boonvisudhi holds Oregon license MD167013.

Kitima Boonvisudhi's primary practice is McKenzie-Willamette Medical Center, at 1460 G Street, Springfield, OR 97477 in Lane County. The practice phone is (541) 726-4402.

Kitima Boonvisudhi's primary practice is McKenzie-Willamette Medical Center in Springfield, Oregon, part of Health Side Partners. Kitima Boonvisudhi is also affiliated with Samaritan Albany General Hospital. The medical group on file is Samaritan Albany General Hospital. Dmand AI also links Kitima Boonvisudhi to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kitima Boonvisudhi practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Kitima Boonvisudhi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Kitima Boonvisudhi's licenses on file in 3 states: Oregon, New York and Wisconsin.

CMS data shows 62 Medicare services from Kitima Boonvisudhi across 2 procedure codes in 2024, for 39 Medicare patients. Medicare paid $2,813 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Kitima Boonvisudhi in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kitima Boonvisudhi's median patient age at 71, with 44% women.

In 2023, Kitima Boonvisudhi wrote 14 Medicare Part D claims. They cover 1 drug, with $158 in total drug cost. In 2022, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Kitima Boonvisudhi for performance year 2024, reported as part of a group. Kitima Boonvisudhi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 4 general payments to Kitima Boonvisudhi from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Organogenesis Inc. paid the most, $125.

Kitima Boonvisudhi graduated from University of Pittsburgh School of Medicine in 1994.